Cargando…

Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study

Pentafecta (continence, potency, cancer control, free surgical margins, and no complications) is an important outcome of prostatectomy. Our objective was to assess the pentafecta achievement between nerve-spring and non-nerve-sparing robot-assisted radical prostatectomy (RARP) in a large single-cent...

Descripción completa

Detalles Bibliográficos
Autores principales: Bejrananda, Tanan, Takahara, Kiyoshi, Sowanthip, Dutsadee, Motonaga, Tomonari, Yagi, Kota, Nakamura, Wataru, Saruta, Masanobu, Nukaya, Takuhisa, Takenaka, Masashi, Zennami, Kenji, Ichino, Manabu, Sasaki, Hitomi, Sumitomo, Makoto, Shiroki, Ryoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517009/
https://www.ncbi.nlm.nih.gov/pubmed/37740045
http://dx.doi.org/10.1038/s41598-023-43092-z
_version_ 1785109244792537088
author Bejrananda, Tanan
Takahara, Kiyoshi
Sowanthip, Dutsadee
Motonaga, Tomonari
Yagi, Kota
Nakamura, Wataru
Saruta, Masanobu
Nukaya, Takuhisa
Takenaka, Masashi
Zennami, Kenji
Ichino, Manabu
Sasaki, Hitomi
Sumitomo, Makoto
Shiroki, Ryoichi
author_facet Bejrananda, Tanan
Takahara, Kiyoshi
Sowanthip, Dutsadee
Motonaga, Tomonari
Yagi, Kota
Nakamura, Wataru
Saruta, Masanobu
Nukaya, Takuhisa
Takenaka, Masashi
Zennami, Kenji
Ichino, Manabu
Sasaki, Hitomi
Sumitomo, Makoto
Shiroki, Ryoichi
author_sort Bejrananda, Tanan
collection PubMed
description Pentafecta (continence, potency, cancer control, free surgical margins, and no complications) is an important outcome of prostatectomy. Our objective was to assess the pentafecta achievement between nerve-spring and non-nerve-sparing robot-assisted radical prostatectomy (RARP) in a large single-center cohort. The study included 1674 patients treated with RARP between August 2009 and November 2022 to assess the clinical outcomes. Cox regression analyses were performed to evaluate the prognostic significance of RARP for pentafecta achievement, and 1:1 propensity score matching (PSM) was performed between the nerve-sparing and non-nerve-sparing to test the validity of the results. Pentafecta definition included continence, which was defined as the use of zero pads; potency, which was defined as the ability to achieve and maintain satisfactory erections or ones firm enough for sexual activity and sexual intercourse. The biochemical recurrence rate was defined as two consecutive PSA levels > 0.2 ng/mL after RARP; 90-day Clavien–Dindo complications ≤ 3a; and a negative surgical pathologic margin. The median follow-up period was 61.3 months (IQR 6–159 months). A multivariate Cox regression analysis demonstrated that pentafecta achievement was significantly associated with nerve-sparing (NS) approach (1188 patients) (OR 4.16; 95% CI 2.51–6.9), p < 0.001), unilateral nerve preservation (983 patients) (OR 3.83; 95% CI 2.31–6.37, p < 0.001) and bilateral nerve preservation (205 patients) (OR 7.43; 95% CI 4.14–13.36, p < 0.001). After propensity matching, pentafecta achievement rates in the NS (476 patients) and non-NS (476 patients) groups were 72 (15.1%) and 19 (4%), respectively. (p < 0.001). NS in RARP offers a superior advantage in pentafecta achievement compared with non-NS RARP. This validation study provides the pentafecta outcome after RARP associated with nerve-sparing in clinical practice.
format Online
Article
Text
id pubmed-10517009
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-105170092023-09-24 Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study Bejrananda, Tanan Takahara, Kiyoshi Sowanthip, Dutsadee Motonaga, Tomonari Yagi, Kota Nakamura, Wataru Saruta, Masanobu Nukaya, Takuhisa Takenaka, Masashi Zennami, Kenji Ichino, Manabu Sasaki, Hitomi Sumitomo, Makoto Shiroki, Ryoichi Sci Rep Article Pentafecta (continence, potency, cancer control, free surgical margins, and no complications) is an important outcome of prostatectomy. Our objective was to assess the pentafecta achievement between nerve-spring and non-nerve-sparing robot-assisted radical prostatectomy (RARP) in a large single-center cohort. The study included 1674 patients treated with RARP between August 2009 and November 2022 to assess the clinical outcomes. Cox regression analyses were performed to evaluate the prognostic significance of RARP for pentafecta achievement, and 1:1 propensity score matching (PSM) was performed between the nerve-sparing and non-nerve-sparing to test the validity of the results. Pentafecta definition included continence, which was defined as the use of zero pads; potency, which was defined as the ability to achieve and maintain satisfactory erections or ones firm enough for sexual activity and sexual intercourse. The biochemical recurrence rate was defined as two consecutive PSA levels > 0.2 ng/mL after RARP; 90-day Clavien–Dindo complications ≤ 3a; and a negative surgical pathologic margin. The median follow-up period was 61.3 months (IQR 6–159 months). A multivariate Cox regression analysis demonstrated that pentafecta achievement was significantly associated with nerve-sparing (NS) approach (1188 patients) (OR 4.16; 95% CI 2.51–6.9), p < 0.001), unilateral nerve preservation (983 patients) (OR 3.83; 95% CI 2.31–6.37, p < 0.001) and bilateral nerve preservation (205 patients) (OR 7.43; 95% CI 4.14–13.36, p < 0.001). After propensity matching, pentafecta achievement rates in the NS (476 patients) and non-NS (476 patients) groups were 72 (15.1%) and 19 (4%), respectively. (p < 0.001). NS in RARP offers a superior advantage in pentafecta achievement compared with non-NS RARP. This validation study provides the pentafecta outcome after RARP associated with nerve-sparing in clinical practice. Nature Publishing Group UK 2023-09-22 /pmc/articles/PMC10517009/ /pubmed/37740045 http://dx.doi.org/10.1038/s41598-023-43092-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Bejrananda, Tanan
Takahara, Kiyoshi
Sowanthip, Dutsadee
Motonaga, Tomonari
Yagi, Kota
Nakamura, Wataru
Saruta, Masanobu
Nukaya, Takuhisa
Takenaka, Masashi
Zennami, Kenji
Ichino, Manabu
Sasaki, Hitomi
Sumitomo, Makoto
Shiroki, Ryoichi
Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study
title Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study
title_full Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study
title_fullStr Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study
title_full_unstemmed Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study
title_short Comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study
title_sort comparing pentafecta outcomes between nerve sparing and non nerve sparing robot-assisted radical prostatectomy in a propensity score-matched study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517009/
https://www.ncbi.nlm.nih.gov/pubmed/37740045
http://dx.doi.org/10.1038/s41598-023-43092-z
work_keys_str_mv AT bejranandatanan comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy
AT takaharakiyoshi comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy
AT sowanthipdutsadee comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy
AT motonagatomonari comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy
AT yagikota comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy
AT nakamurawataru comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy
AT sarutamasanobu comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy
AT nukayatakuhisa comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy
AT takenakamasashi comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy
AT zennamikenji comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy
AT ichinomanabu comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy
AT sasakihitomi comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy
AT sumitomomakoto comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy
AT shirokiryoichi comparingpentafectaoutcomesbetweennervesparingandnonnervesparingrobotassistedradicalprostatectomyinapropensityscorematchedstudy